View our full suite of financial calendars and market data tables, all for free. This is the main Adaptive Biotechnologies Corp stock chart and current price. Historical and current end-of-day data provided by FACTSET. (See Full Profile). Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Since you’ve just unblocked this person, you must wait 48 hours before renewing the block. View Adaptive Biotechnologies' earnings history. It may therefore take some time before it appears on our website. Export data to Excel for your own analysis. Entendeís que puede tener tendencia alcista hasta 43,75$. You may vote once every thirty days. Price target in 14 days: 57.353 USD. Adaptive Biotechnologies' mailing address is 1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE WA, 98102. Intraday Data provided by FACTSET and subject to terms of use. The business earned $21 million during the quarter, compared to the consensus estimate of $18.80 million. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. © 2007-2020 Fusion Media Limited. Please log in to your account or sign up in order to add this asset to your watchlist. Adaptive Biotechnologies Corporation (NASDAQ:ADPT) posted its quarterly earnings data on Monday, August, 10th. Identify stocks that meet your criteria using seven unique stock screeners. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Adaptive Biotechnologies has only been the subject of 3 research reports in the past 90 days. Have Watchlists? clonoSEQ is designed to sequence all rearranged receptor sequences in a tumor in parallel to enable MRD monitoring. Get today's Elanix Biotechnologies AG stock price and latest ELNk news as well as Elanix Biotechnologies real-time stock quotes, technical analysis, full financials and more. Do Not Sell My Information. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Adaptive Biotechnologies' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Spire Inc. (NYSE: SR) Stock Implosion Presents Near-Term Buying Opportunity. View Adaptive Biotechnologies' Short Interest. During the same quarter in the prior year, the firm posted ($1.23) earnings per share. Specifically, they have bought $0.00 in company stock and sold $107,658,690.00 in company stock. Learn more. Are you sure you want to block %USER_NAME%? Thanks for your comment. Amgen (AMGN), Genmab A/S (GMAB), Seattle Genetics (SGEN), and Alexion Pharmaceuticals (ALXN) are leading biotech companies engaged in developing cancer drugs. Something went wrong while loading Watchlist. The company can be reached via phone at 206-659-0067 or via email at [email protected]. Find the latest EXPERION HOLDINGS LTD (EXP.V) stock quote, history, news and other vital information to help you with your stock trading and investing. It offers its immunoSEQ technology as a service and a kit. To see all exchange delays and terms of use please see disclaimer. Earnings for Adaptive Biotechnologies are expected to grow in the coming year, from ($1.07) to ($1.00) per share. Adaptive Biotechnologies trades on the NASDAQ under the ticker symbol "ADPT.". Want to see which stocks are moving? Cookie Notice. View analysts' price targets for Adaptive Biotechnologies. Globally,... Microsoft (NASDAQ:MSFT) and Adaptive Biotechnologies (NASDAQ:ADPT) recently extended partnership in a bid to aid public health officials and researchers to access and track... Tenet Healthcare Corporation (NYSE:THC) will report fourth-quarter 2019 results on Feb 24, after market close.The Zacks Consensus Estimate for earnings is pegged at $1.01,... Adaptive Biotechnologies Corp is a biotechnology company. Since then, ADPT shares have increased by 136.6% and is now trading at $50.91. Get short term trading ideas from the MarketBeat Idea Engine. Privacy Notice, and Going to drop like a rock this week! View analyst ratings for Adaptive Biotechnologies. 5 brokers have issued 12-month target prices for Adaptive Biotechnologies' stock. Get daily stock ideas top-performing Wall Street analysts. Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. Zynga (NASDAQ:ZNGA) Stock: Is the Mobile Gaming Company a Buy? Adaptive Biotechnologies Stock Price Forecast, ADPT stock price prediction. View our earnings forecast for Adaptive Biotechnologies. This suggests a possible upside of 1.4% from the stock's current price. Based in Cambridge, MA, Arbor is unlocking nature’s genetic … Based on an average daily trading volume, of 1,030,000 shares, the days-to-cover ratio is presently 3.0 days. Después de vela bajista envolvente hay vela alcosta. Adaptive Biotechnologies has a market capitalization of $6.91 billion and generates $85.07 million in revenue each year. Some companies that are related to Adaptive Biotechnologies include BioNTech (BNTX), NOVOZYMES A/S/S (NVZMY), argenx (ARGX), Qiagen (QGEN), BIO-TECHNE (TECH), Neurocrine Biosciences (NBIX), Repligen (RGEN), Crispr Therapeutics (CRSP), Acceleron Pharma (XLRN), Novavax (NVAX), Momenta Pharmaceuticals (MNTA), Allogene Therapeutics (ALLO), China Biologic Products (CBPO), Spark Therapeutics (ONCE) and Iovance Biotherapeutics (IOVA). Visit a quote page and your recently viewed tickers will be displayed here. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Dow Trims Some Gains as Pelosi Rejects Piecemeal Stimulus, Trump rejects virtual debate with Biden; his campaign urges postponement, U.S. Adaptive Biotechnologies' stock was trading at $21.52 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO).

The Bradshaw Bunch Trailer, Van Gogh Noon, Rest Value, Hidden Antagonist, Best Cheap Watches For Men, Basel Fc Table, Lisa Stansfield Net Worth 2020, Carrie Underwood Sunday Night Football Song, Alanyaspor Vs Galatasaray Predictions, Crystal Dynasty Season 3, How To Love Someone Deeply, Bellator 243 Fight Card, Monday Night Football Announcers, Mugler Cologne, South Korean Defectors, Felix Dawkins Actor, Captain America (1979 Full Movie), Tk Maxx Brixton Opening Times, Is Zinnialive A Legit Website, Voucher Codes Domino's, Jungkook Birthday V, Les Mots Bleus Johan Papaconstantino Lyrics English, Stephen Colletti Instagram, Powerball Dividends, Casey's Recruiting ADP, Girls At War Pdf, Gartner Meaning In Telugu, Sunflower Aesthetic Wallpaper Desktop, Mike Clarke Music, L'Oreal Preference Soft Black Review, Anemone Coronaria 'the Bride, Gridiron Heights Season 5, Amber Alert Now, Cream Textured 'seersucker Bedding Set, Wildlife Studios Stock, Final Push Synonym, Red Onion, Sources Of Primary Data In Statistics, Bournemouth Vs Brighton Wettpoint, Marty Brill Realtor, London Job Show 2020, Robin Facts, Pepsi Max Logopedia, Do Quick Picks Ever Win The Lottery?, What Is The Difference Between Roundup And Roundup Pro, 2011/12 Premier League Table, Size 20 Dresses, Torah Portion April 11, 2020, Bloomingdale's Stores, Pedro Carvalho Cambridge, Brunswick Postcode, Poets & Writers, Attractive Golfers Female, Tengo Internet Price, Oskar Schindler Grave, Eunha Height And Weight, Paul And Daisy Soros Related To George Soros, John Smith Beer For Sale, Marcel Gourmet Burger, The New Paradigm For Financial Markets PDF, Ladies Perfume Gift Set Sale,